Griffon Pharmaceuticals appoints Dr. Marc Cluzel to Board of Directors MONTREAL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Montreal-based biopharmaceutical company Griffon Pharmaceuticals Inc. (“Griffon”) announced today that Marc Cluzel, MD, PhD, joins the company’s Board of...

Metreleptin and Lipodystrophy Data Presented at the International Meeting of Pediatric Endocrinology VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...